Despite evidence of the link between side effects of Enfamil and NEC, Mead Johnson has done little to warn parents or doctors, lawsuit alleges.
Verdict comes after two previous juries ordered Abbott Laboratories and Mead Johnson to pay millions of dollars in damages to families of children who developed NEC from Similac or Enfamil.
Studies have shown that side effects of Similac and Enfamil formula substantially increase the risk of NEC for premature newborns, lawsuit notes.
Early breastfeeding, even if it only lasts a few days, could be instrumental in protecting a newborn's health, researchers indicate.
Michigan mother claims that Abbott Laboratories has known for years about the risk that cow's milk-based Similac formula may cause NEC in premature infants.
Parties have agreed that a series of four bellwether NEC trials will be ready to go before federal juries in May 2025, August 2025, November 2025 and February 2026.
Two previous state trials involving lawsuits over NEC infant formula risks led to verdicts awarding families more than half a billion dollars.
Specific starting dates for each of the first four baby formula NEC lawsuit bellwether trials in the federal MDL will be set at a future status conference.
Proposed Similac recall settlement would resolve personal injury and wrongful death lawsuits linked to infant formula contaminated with cronobacter and salmonella.
After she was fed Similac formula as an infant, a now adult woman indicates that she developed permanent and disabling NEC injuries, which continue to cause medical and financial challenges.
